We demonstrate that the cytogenetically de®ned translocation t(X;1)(p11.2;p34) observed in papillary renal cell carcinomas results in the fusion of the splicing factor gene PSF located at 1p34 to the TFE3 helix ± loop ± helix transcription factor gene at Xp11.2. In addition we de®ne an X chromosome inversion inv(X)(p11.2;q12) that results in the fusion of the NonO (p54 nrb ) gene to TFE3. NonO (p54 nrb ), the human homologue of the Drosophila gene NonA diss which controls the male courtship song, is closely related to PSF and also believed to be involved in RNA splicing. In each case the rearrangement results in the fusion of almost the entire splicing factor protein to the TFE3 DNA-binding domain. These observations suggest the possibility of intriguing links between the processes of RNA splicing, DNA transcription and oncogenesis.
Introduction
Renal cell carcinoma (RCC), the most common cancer of kidneys, can be divided into several tumor subtypes including, clear cell, granular cell, sarcomatoid and papillary based on histological appearance (Murphy et al., 1994; Savage, 1994) . The clear cell carcinomas are characterized in cytogenetic and molecular studies by frequent abnormalities of the short arm of chromosome 3, including loss of heterozygosity. The von Hippel-Lindau (VHL) disease, a dominantly inherited cancer syndrome in which family members develop multiple bilateral clear cell renal carcinomas, as well as tumors of the brain, spine and eye, has been mapped to this chromosome region. The VHL gene has now been cloned and mutations of this gene are found in a high proportion of sporadic clear cell, granular cell and sarcomatoid tumors Herman et al., 1994) .
By comparison, papillary renal cell carcinomas, which account for 10 ± 20% of renal cell tumors, do not exhibit VHL gene loss or mutation . A high frequency of loss of chromosome Y and trisomy of chromosome 7 has, however, been reported in papillary RCC (Kovacs et al., 1987 (Kovacs et al., , 1991 Kovacs, 1993; van den Berg et al., 1993; Elfving et al., 1995) and a speci®c translocation between chromosomes X and 1, t(X;1)(p11.2;q21.2), has been identi®ed in cytogenetic studies (de Jong et al., 1986; Meloni et al., 1993; Mitelman, 1994; Shipley et al., 1995; Tonk et al., 1995) . It has recently been shown (Sidhar et al., 1996; Weterman et al., 1996a, b) that this translocation results in the fusion of a novel chromosome 1 gene, called PRCC, to the chromosome X gene TFE3, which encodes a member of the basic-helix ± loop ± helix family of transcription factors originally identi®ed by its ability to bind to mE3 elements in the immunoglobin heavy chain intronic enhancer (Beckmann et al., 1990) . The PRCC-TFE3 chimaeric gene encodes a fusion protein in which N-terminal PRCC sequences containing a proline-rich domain, become fused to the TFE3 DNA-binding domain (Sidhar et al., 1996; Weterman et al., 1996a) .
Cytogenetic studies have also identi®ed other abnormalities of the Xp11 region in renal cell carcinomas. Cases containing t(X;17)(p11.2;q25), del(X)(p11) and t(X;10)(p11.2;q23) have been reported in papillary RCC (Tomlinson et al., 1991; Ohjimi et al., 1993; Dijkuizen et al., 1995) while translocations involving Xp11 and 1p34, t(X;1)(p11.2;p34), have been identi®ed in a papillary RCC and two RCCs of unspeci®ed type (Kovacs et al., 1987; Dijkuizen et al., 1995; Yoshida et al., 1995) . These observations raise the possibility that in a proportion of papillary RCC the TFE3 gene at Xp11.2 may be involved in fusions with genes other than PRCC. In agreement with this idea in the present study we report that the TFE3 gene may also become fused to the splicing factor genes PSF and NonO(p54 nrb ) in papillary renal cell carcinoma.
Results

Abnormalities of the TFE3 gene in the UOK109 and UOK145 cell lines
Southern blot analysis using a probe corresponding to the 5' end of the TFE3 gene was used to screen for rearrangements of this gene in papillary renal cell carcinoma cell lines. Rearrangements were detected in the UOK109 and UOK145 cell lines but not in the UOK112 and UOK132 cell lines (Figure 1a ). Additional evidence for alteration of the TFE3 gene was provided by the results of Northern analyses which showed abnormal patterns of TFE3 transcripts in the UOK109 and UOK145 cell lines (Sidhar et al., 1996) . However, in parallel RT ± PCR experiments using 5' PRCC primers and 3' TFE3 primers we failed to detect fusion of the PRCC and TFE3 genes (results not shown).
The karyotype of the UOK145 cell line was as follows: 41,X,-X,der(1)t(X;1) (p11.2;p34),76,78,+14,i (17)(q10), 718,720,721,722, +mar [5] /41,X,-X,der(1) t (X;1) (p11.2; p34), add (2) (q37), 73, 76,78,+14, i (17) (q10),718,721, 722,+mar[3] . Notably the resulting rearrangement t(X;1)(p11.2;p34), was identical to that previously reported in three renal tumors (Kovacs et al., 1987; Dijkuizen et al., 1995; Yoshida et al., 1995) suggesting that this is a recurrent abnormality in renal cell cancers. The translocation involving chromosomes X and 1 was con®rmed by FISH analysis and disruption of the markers¯anking the TFE3 gene at Xp11.2 identi®ed (Figure 1c, d and e). The karyotype of the cell line UOK109 was determined as 47,XY, +add (3) (q10),75,76, del (6) (q21),+add (7) (q32), 79, 714,+16,+2mar. This analysis failed to identify any abnormalities of the X chromosome. However, when FISH studies were performed using probes that¯anked the TFE3 gene at Xp11.2 it became apparent that a pericentric inversion of the X chromosome had occurred described as inv(X)(p11.2;q12) (Figure 1f and g). When taken together these observations suggested that in the UOK109 and UOK145 cell lines the TFE3 gene may have translocation partners other than PRCC which is involved in the t(X;1)(p11.2;q21.2) (Sidhar et al., 1996; Weterman et al., 1996a) .
Fusion to the PSF gene in UOK145
To identify sequences fused to the TFE3 gene in the UOK145 cell line, 5'-RACE was performed using a TFE3 gene exon 4 primer (Sidhar et al., 1996) . The sequence of the product obtained (Figure 2a ) diverged from the normal TFE3 sequence 5' to exon 4. Database searches of the unique 5' sequences revealed that they were identical to the human PSF splicing factor gene (Patton et al., 1993) . The splicing reaction involves two steps. In step I unspliced pre-mRNA is converted into separate exon 1 and lariat-intron-exon 2 structures. In step II exons 1 and exons 2 are joined and an excised lariat-intron is formed. PSF is a component of the spliceosome complex which catalyses these reactions and has been shown to be required for catalytic step II of the splicing reaction (Gozani et al., 1994) . The 712aa PSF protein contains several distinct regions (Figure 3 Northern blot analysis of RNA from human cell lines probed with a TFE3 probe that spanned from positions 232-1513 of the TFE3 cDNA sequence (Accession Number X96717). RNAs were from: RMS, rhabdomyosarcoma; HT1080, ®brosarcoma; SK melanoma; and UOK109, UOK109LN, UOK145 and UOK124 papillary renal carcinoma cell lines. UOK109 and UOK109LN were derived from primary and lymph node tumors from the same patient. Representative images from the FISH studies are shown in (c ± g). The derivative 1 chromosome, der(1)t(X;1)(p11.2;p34), from UOK145 is shown following hybridization to (c) a chromosome 1 paint, (d) a chromosome X paint and (e) the marker GATA (green), normally localising telomeric to TFE3 at Xp11 and a probe for the pericentric region of chromosome 1 (red). (f) shows the markers GATA (green) and pTAK8 (red), which lie telomeric and centromeric to TFE3 in the Xp11 region, respectively, hybridizing to the normal X chromosome in UOK145. The inv(X)(p11.2;q12) in UOK109 is demonstrated in (g) with the pTAK8 YAC (red), which is normally at Xp11 but centromeric to GATA (green), localising below the centromere on this chromosome including (i) an N-terminal domain rich in proline and glutamine and (ii) two conserved RNA-binding domains (Patton et al., 1993) . Notably the PSF-TFE3 hybrid transcript detected in UOK145 is predicted to encode a fusion protein containing almost the entire PSF protein fused to the C-terminal TFE3 DNAbinding domain (Figure 3 ).
Fusion to the NonO (p54 nrb ) gene in UOK109
To identify sequences fused to the TFE3 gene in the UOK109 cell line, TFE3 5'-RACE and 3'-RACE products were obtained. For both 5' and 3'-RACE, sequences were obtained that diverged from known TFE3 sequences at the exon 3-exon 4 junction (eg, the 5'-RACE product is shown in Figure 2b ). Database searches of the new sequences present in the 5'-RACE and 3'-RACE products revealed that they exactly matched adjacent regions of a gene designated NonO (p54 nrb ) that is closely related to PSF (Dong et al., 1993; Yang et al., 1993) .
The 471 amino acid NonO (p54 nrb ) protein contains several distinct domains ( Figure 3 ) including (i) a short N-terminal sequence composed entirely of histidine, glutamine and proline residues, (ii) a helix ± turn ± helix domain¯anked by charged amino acids that is responsible for binding to the octamer sequence in double stranded DNA and (iii) a short C-terminal proline-rich region. The NonO (p54 nrb ) protein has a region of 320 amino acids with 71% identity and 7% similarity to a 320aa region of PSF (Patton et al., 1993; Dong et al., 1993; Yang et al., 1993 (Figure 3 ) lack the TFE3 acidic activation domain (AAD) indicating that this sequence is not essential for transformation.
RT ± PCR detection of hybrid transcripts
The presence of a PSF-TFE3 hybrid transcript encoded by the der(1) chromosome in the UOK145 cell line was con®rmed by RT-PCR. Using 5'-PSF and 3'-TFE3 primers a product of the predicted size was observed for UOK145 but not in other renal cell lines examined (Figure 4 ). The der(X) chromosome resulting from the t(X;1)(p11.2;p34) translocation is absent in UOK145 and indeed we failed to detect the reciprocal TFE3-PSF hybrid transcript that would be encoded by the der(X) in this cell line (results not shown). Using a similar approach we con®rmed the presence of both the NonO (p54 (Figure 4 ) demonstrated that fusion of the X chromosome genes NonO and TFE3 in the male UOK109 cell line was associated with the loss of both normal NonO and normal TFE3 transcripts.
Discussion
In these studies we report that the UOK145 papillary renal cell carcinoma cell line contains a t(X;1)(p11.2;p34) translocation that results in the fusion of the PSF gene located on chromosome arm 1p to the TFE3 transcription factor gene. This translocation has been observed previously in renal tumors (Kovacs et al., 1987; Dijkuizen et al., 1995; Yoshida et al., 1995) and therefore represents a recurrent abnormality in this tumor type. We also demonstrated that in the UOK109 cell line an inv(X)(p11.2;q12) results in the fusion of the NonO (p54 nrb ) gene to the TFE3 gene. The abnormality inv(X)(p11.2;q12) has not been cytogenetically detected previously in renal carcinoma but this subtle alteration is not evident by standard cytogenetic examination. In previous studies we showed that a novel gene called PRCC becomes fused to the TFE3 gene in papillary renal carcinomas containing the t(X;1)(p11.2;q21.2) (Sidhar et al., 1996) . Taken together, our observations, therefore, demonstrate consistent alteration of the TFE3 gene in papillary renal cell carcinoma but show that TFE3 may have a variety of fusion partners. Notably, a t(X;17)(p11.2;q25) translocation (Tomlinson et al., 1991) and a t(X;10)(p11.2;q23) translocation (Dijkuizen et al., 1995) have also been reported in papillary renal cell carcinoma suggesting that the TFE3 gene may have partners in addition to those currently identi®ed.
Fusion of a single gene to several distinct partners has also been observed for translocations found in sarcomas and haematopoietic cancers. For example, in acute myelocytic leukemia the homeobox gene MLL at 11q23 can have a large variety of fusion partners (Rabbitts, 1994) . Similarly in Ewing's sarcoma, the 5' region of the EWS gene at 22q12 can become fused to the FLI1, ERG and ETV1 genes, three members of the family of transcription factor genes located respectively on chromosomes 11, 21 and 7 (Zucman et al., 1993; Jeon et al., 1995) . In alveolar rhabdomyosarcoma 3' FKHR sequences on chromosome 13 can become joined to either 5' PAX3 sequences located on chromosome 2 or 5' PAX7 sequences on chromosome 1 (Galili et al., 1993; Davis et al., 1994) .
Previous analysis of the fusion between the PRCC and TFE3 genes indicated that it is the generation of the PRCC-TFE3 hybrid transcript, rather than the formation of the TFE3-PRCC hybrid transcript, that is a consistent feature associated with the t(X;1)(p11.2;q21.2) translocation. By analogy it would be expected that the generation of the NonO (p54 nrb )-TFE3 and PSF-TFE3 hybrid transcripts are the key events in transformation. In agreement with this observation we failed to detect the reciprocal TFE3-PSF transcript in UOK145 cells.
Since work on the identi®cation of fusions of the TFE3 gene to PRCC, NonO and PSF genes has all been carried out on immortal cell lines it could be proposed that this fusion could be an artefact of in vitro selection. However this possibility seems unlikely since the t(X;1)(p11.2;q21.2) and t(X;1)(p11.2;p34) translocations that result in these fusions were originally observed in cultures of primary tumor material (Kovacs et al., 1987; de Jong et al., 1986; Meloni et al., 1993; Mitelman, 1994; Dijkuizen et al., 1995; Tonk et al., 1995; Yoshida et al., 1995) . In addition, we have directly detected alteration of the TFE3 gene in primary renal tumor material (DS and JS unpublished) .
Several lines of circumstantial evidence have suggested links between RNA processing, transcription factors and oncogenesis. For example, WT1 protein which has been demonstrated to act as a transcriptional regulator (Hastie, 1994) was shown to be able to associate with spliceosomes and to coiledbodies, nuclear organelles of unknown function that contain components of the spliceosome (Larsson et al., 1995) . In Friend spleen focus forming virus-induced Figure 3 Schematic representation of wild type PSF, NonO (p54 nrb ) and TFE3 proteins and of the PSF-TFE3 and NonO-TFE3 chimaeric proteins present in respectively UOK145 and UOK109. The PSF protein is 712 amino acids in length and contains an Nterminal domain rich in proline and glutamine (PQ), a region rich in proline (P) and tandem RNA-binding domains (RBD). The 471 amino acid NonO protein contains regions rich in glutamine and histidine (QH) and proline (P), tandem RNA-binding domains (RBD), and a helix-turn-helix-charged (HTH, +/7) region implicated in DNA binding. The regions of conservation between PSF and NonO which encompasses the RBD region and NonO HTH, +/7 region is shown by the bar. The TFE3 protein contains acidic activation (AAD) and DNA binding domains (bHLH;Z) and has an overall length of 575 amino acids. To check the structure of the TFE3 protein we isolated and sequenced normal TFE3 cDNA clones. The predicted structure, which is shown in this ®gure, is in agreement with that reported by Weterman et al. (1996a) . RT ± PCR of RNA from the UOK109 cell line has been used to con®rm the entire structure shown in this ®gure. The arrows represent the positions of fusion erythroleukemia, insertional mutagenesis can occur adjacent to the Spi-1 gene resulting in overexpression of the normal Spi-1/PU1 protein, a member of the Etsfamily of DNA-binding transcription factors. Recent evidence has shown that the 55 kDa Spi-1/PU1 protein can also bind to the NonO (p54 nrb ) protein and aect the splicing process in vitro (Hallier et al., 1996) .
In the present study we provide a more direct link between the splicing process, transcription factors and oncogenesis by demonstrating fusion of the splicing factor genes PSF and NonO (p54 nrb ) to the TFE3 transcription factor gene in papillary renal cell carcinomas. A notable feature of this fusion is that in each case it results in fusion of almost the entire splicing factor to the DNA binding domain of TFE3. It is therefore possible that the PSF-TFE3 and NonO(p54 nrb )-TFE3 fusions may retain activity in both splicing and DNA transcriptional control and it is interesting to speculate that the resulting interference between these two processes may represent a new mechanism of tumor development. This may provide a fascinating area of investigation for future studies.
Previous studies on the t(X;1)(p11.2;q11.2) translocation indicated that generation of the PRCC-TFE3 fusion protein was invariably associated with the loss of transcription of the normal X chromosome TFE3 gene. This led to the proposal that the fusion may have a dual function in both generating a fusion protein and in removing the product of the normal gene. In the current study we did, however, detect a normal TFE3 transcript in the UOK145 cell line in addition to the hybrid PSF-TFE3 transcript (as shown in ®gure 4). This observation would be consistent with the view that removal of normal TFE3 transcript is not an essential step in the transformation process.
It has been proposed that renal cell carcinomas bearing abnormalities of Xp11.2 may constitute a subgroup distinct from the classic histologically de®ned papillary carcinoma (Meloni et al., 1993) . This idea was based on initial cytogenetic observations showing that tumors containing alterations of Xp11.2 were found entirely in male patients and arose mainly in children and young adults, although sporadic renal cell carcinoma is a disease that is most common in the ®fth to seventh decades of life. We have now found alterations of the TFE3 gene in ®ve of seven papillary renal cell carcinoma cell lines examined. In agreement with these earlier conclusions the average age of onset of these ®ve tumors (27 years) was lower than that generally observed for renal cell carcinoma. In addition, three tumors harbouring TFE3 abnormalities arose in females demonstrating that this alteration is not restricted to male patients. The advances reported should now allow analysis of larger series of tumors to determine its true age and sex distribution of patients with TFE3 abnormalities and to assess whether this translocation can be used as a diagnostic or prognostic marker. It may also be interesting to see, in studies of larger tumor series, whether fusion of the TFE3 gene to dierent partners correlates with particular histological and biological phenotypes.
Materials and methods
Cell lines
The UOK145, UOK109, UOK112 and UOK132 cell lines were derived from primary papillary renal cell carcinoma specimens as described (Anglard et al., 1992) . The cell lines were derived respectively from tumors arising in an 18 year old female, a 39 year old male, a 67 year old male and a 63 year old female.
Cytogenetics and FISH analysis
Cytogenetic analysis of UOK109 and UOK145 was carried out using standard procedures. Chromosome 1 and X paints and a probe for the pericentric region of chromosome 1 were used singly or in combination with dierentially labeled YAC probes as previously described in order to con®rm the origin of the derivative 1 and X chromosomes (Shipley et al., 1993 (Shipley et al., , 1995 . YAC clones for GATA and pTAK8 (Shipley et al., 1995) lie telomeric and centromeric to TFE3 at Xp11 and were labeled with green and red¯uorochromes, respectively. These YACs were cohybridised to chromosome preparations of the two cell lines and analysed as detailed previously (Shipley et al., 1993 (Shipley et al., , 1995 .
Analysis of DNA and RNA
Preparation of genomic DNA and cytoplasmic RNA were carried out as described (Clark et al., 1994) . Restriction Detection of PSF-TFE3 and NonO-TFE3 hybrid transcripts by RT ± PCR (upper two panels). RT ± PCR was performed using 5' PSF or 5'-NonO primers together with 3' TFE3 primers. Normal PSF, NonO and TFE3 transcripts were detected by RT ± PCR using pairs of primers that¯anked the position of translocations within each of these genes. For primers sequences see the Materials and methods section. RNAs used for these experiments were from the UOK109 and UOK145 papillary renal cell carcinoma cell lines and the following human tumor samples; the HA2243 synovial sarcoma cell line; the SK23 melanoma cell line; the RD rhabdomyosarcoma cell lines; and the HTB86 Ewings sarcoma cell line endonuclease digestions and Southern blot analysis were carried out as described previously. (Clark et al., 1994) .
RT ± PCR analysis
To detect PSF-TFE3 hybrid transcripts reverse transcribed RNA was subject to ampli®cation using the PSF primer 5'-TGGTGGTGGCATAGGTTATG-3' (forward primer) and TFE3 primer 5'-CGTTTGATGTTGGGCAGCTC-3' (reverse primer). NonO (p54 nrb )-TFE3 hybrid transcripts were detected using the NonO (p54 nrb ) primer 5'-GAGAAACTA-GACACAGCAAC-3' (forward primer) and the TFE3 primer 5'-CTTTCTTCTGCCGTTCCTTC-3' (reverse primer). PRCC-TFE3 hybrid transcripts were detected using the PRCC primer 5'CCAAGCCAAAGAAGAGGA-3' (forward primer) and the TFE3 primer 5'-AGTGTGGTG-GACAGGTACTG-3' (reverse primer). Normal PSF transcripts were detected using the forward PSF primer described above together with the reverse PSF primer 5'-TCTACCATATCCTGCTGGAG-3'. Normal NonO transcripts were detected using the forward NonO primer described above and the NonO reverse primer 5'-CAAGTG-GACCGCAACATCAAG-3'. Normal TFE3 transcripts were detected using the primers 5'-CCCGCAAGTGC-CCAGCCACTG-3' (forward primer, exon 3) and 5'-CAGTTCCTTGATCCTGTCG-3' (reverse primer, exon 4). As positive controls to con®rm that each RNA sample could yield products RT ± PCR ampli®cation was carried out with actin primers as described previously (Sidhar et al., 1996) . In these analyses all reverse transcribed samples generated an actin PCR product of the expected size. Ampli®cation conditions were 938C for 20 s, 598C for 30 s (cycles 7 ± 36) and 688C for 30 s for 30 cycles using Expand High Fidelity DNA polymerase (Boehringer Mannheim) in a ®nal volume of 25 ml. For the ®rst six cycles touch down annealing temperatures were 618C (62) and 598C (62) and 578C (62). The products were separated by electrophoresis in agarose gels followed by staining with ethidium bromide.
5'RACE and 3'RACE
For 5'RACE 1 mg of RNA was reverse transcribed using Superscript II reverse transcriptase using the TFE3 speci®c primer CAGTTCCTTGATCCTGTCGA and then tailed with 5'-polyC as described (Sidhar et al., 1996) . Amplification of cDNA 5' ends was then performed using the ®rst round PCR primers 5'-CTTTCTTCTGCCGTTCCTTC-3' (TFE3 reverse primer) and the GI tag primer 5'-GAC-TCGAGTCGACATCGGGIIGGGIIGGGIIG-3' where I is inosine. Aliquots of the reaction were then subject to nested PCR using the reverse primer 5'-CGTTTGATGTTG-GGCAGCTC-3' (TFE3 reverse primer) and tag primer 5'GACTCGAGTCGACATC-3'. For 3'-RACE reverse transcription was performed using the tagged random hexamer primer 5'-GACTCGAGTCGACATCNNNNNN-3'. 3'-RACE was then performed using the TFE3 forward primer 5'-CCCGCAAGTGCCCAGCCACTG-3' together with the tag primer 5'-GACTCGAGTCGACATC-3'. Nested PCR was then performed using the TFE3 forward primer 5'-TCACCATCGGGTCCAGCTCA-3' together with the tag primer. PCR conditions for both 5' PCR and 3'RACE were 938C for 15 s; 578C for 30 s and 688C for 30 s for 30 cycles.
cDNA libraries A cDNA library made from human placental DNA in the pcDM8 vector were kindly provided by the Sanger Centre, Cambridge, UK.
DNA sequencing
DNA sequencing was performed exactly as described previously (Sidhar et al., 1996) .
Abbreviations RCC, Renal cell carcinoma; RT ± PCR, reverse transcription-polymerase chain reaction; VHL, von Hippel-Lindau; AAD, acidic activation domain.
Accession No. 5'-TFE3: X96717.
